Inhibition of NF-κB signaling via tyrosine phosphorylation of Ymer

Biochemical and Biophysical Research Communications

Volumn 378, Issue 4, 2009, Pages 744-749

  Kameda, Hiroyuki ^a   Watanabe, Masashi ^a   Bohgaki, Miyuki ^a   Tsukiyama, Tadasuke ^a   Hatakeyama, Shigetsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

A20; NF B; Phosphorylation; Ubiquitin; Ymer

Indexed keywords

A20 PROTEIN; AGAR; EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; PHOSPHOPROTEIN; POLYUBIQUITIN; PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; YMER PROTEIN; CCDC50 PROTEIN, HUMAN; SIGNAL PEPTIDE; TYROSINE;

ARTICLE; CARCINOGENIC ACTIVITY; CELL CULTURE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; CELL LINE; CELL TRANSFORMATION; DRUG ANTAGONISM; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION;

CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TYROSINE;

EID: 57849098056     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.102     Document Type: Article

References (29)

1. Ghosh S., May M.J., and Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16 (1998) 225-260
2. Hayden M.S., and Ghosh S. Signaling to NF-κB. Gene Dev. 18 (2004) 2195-2224
3. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388 (1997) 548-554
4. Lee F.S., Hagler J., Chen Z.J., and Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88 (1997) 213-222
5. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., and Ben-Neriah Y. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396 (1998) 590-594
6. Hatakeyama S., Kitagawa M., Nakayama K., Shirane M., Matsumoto M., Hattori K., Higashi H., Nakano H., Okumura K., Onoe K., Good R.A., and Nakayama K. Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. USA 96 (1999) 3859-3863
7. Lin K.I., DiDonato J.A., Hoffmann A., Hardwick J.M., and Ratan R.R. Suppression of steady-state, but not stimulus-induced NF-κB activity inhibits alphavirus-induced apoptosis. J. Cell Biol. 141 (1998) 1479-1487
8. Ea C.K., Deng L., Xia Z.P., Pineda G., and Chen Z.J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
9. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., and Chen Z.J. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15 (2004) 535-548
10. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., Ma A., Koonin E.V., and Dixit V.M. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430 (2004) 694-699
11. Wu C.J., Conze D.B., Li T., Srinivasula S.M., and Ashwell J.D. NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-κB activation. Nat. Cell Biol. 8 (2006) 398-406
12. Dixit V.M., Green S., Sarma V., Holzman L.B., Wolf F.W., O'Rourke K., Ward P.A., Prochownik E.V., and Marks R.M. Tumor necrosis factor- induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265 (1990) 2973-2978
13. Lee E.G., Boone D.L., Chai S., Libby S.L., Chien M., Lodolce J.P., and Ma A. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289 (2000) 2350-2354
14. Gallagher J., Howlin J., McCarthy C., Murphy E.P., Bresnihan B., FitzGerald O., Godson C., Brady H.R., and Martin F. Identification of Naf1/ABIN-1 among TNF-α-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett. 551 (2003) 8-12
15. Liu W.K., Yen P.F., Chien C.Y., Fann M.J., Su J.Y., and Chou C.K. The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKγ to block activation of the transcription factor NF-κB and potentiate apoptosis. Biochem. J. 378 (2004) 867-876
16. Blagoev B., Ong S.E., Kratchmarova I., and Mann M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 22 (2004) 1139-1145
17. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.M., Polakiewicz R.D., and Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23 (2005) 94-101
18. Tashiro K., Konishi H., Sano E., Nabeshi H., Yamauchi E., and Taniguchi H. Suppression of the ligand-mediated downregulation of epidermal growth factor receptor by Ymer, a novel tyrosine phosphorylated and ubiquitinated protein. J. Biol. Chem. 281 (2006) 28919-28931
19. Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., and White F.M. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4 (2005) 1240-1250
20. Bohgaki M., Tsukiyama T., Nakajima A., Maruyama S., Watanabe M., Koike T., and Hatakeyama S. Involvement of Ymer in suppression of NF-κB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim. Biophys. Acta 1783 (2008) 826-837
21. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., and Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93 (1998) 1231-1240
22. Morita S., Kojima T., and Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy 7 (2000) 1063-1066
23. lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J. 6 (1987) 2727-2734
24. Delhase M., Hayakawa M., Chen Y., and Karin M. Positive and negative regulation of IκB kinase activity through IKK subunit phosphorylation. Science 284 (1999) 309-313
25. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., Marinkovich M.P., Tao S., Lin Q., Kubo Y., and Khavari P.A. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 (2003) 639-643
26. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., Yamada T., and Hatanaka M. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 15 (1996) 873-887
27. Karin M. Nuclear factor-κB in cancer development and progression. Nature 441 (2006) 431-436
28. Cusack Jr. J.C., Liu R., Houston M., Abendroth K., Elliott P.J., Adams J., and Baldwin Jr. A.S. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res. 61 (2001) 3535-3540
29. Hideshima T., Neri P., Tassone P., Yasui H., Ishitsuka K., Raje N., Chauhan D., Podar K., Mitsiades C., Dang L., Munshi N., Richardson P., Schenkein D., and Anderson K.C. MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo. Clin. Cancer Res. 12 (2006) 5887-5894